On Tuesday, Shares of Seattle Genetics, Inc. (NASDAQ:SGEN), subtract -0.52% and closed at $59.42 in the last trading session. The last trading range of the stock ranges between $58.50 and $60.81. Seattle Genetics, Inc. (SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) recently declared completion of patient enrollment in the ECHELON-2 clinical trial. ECHELON-2 is a global phase 3 randomized trial evaluating ADCETRIS (brentuximab vedotin) as part of a frontline combination chemotherapy regimen in patients with formerly untreated CD30-positive mature T-cell lymphoma (MTCL). ADCETRIS is an antibody-drug conjugate (ADC) directed to CD30, which is expressed on several types of non-Hodgkin lymphoma, counting subsets of MTCL, in addition to Hodgkin lymphoma. ADCETRIS is presently not approved for the frontline treatment of MTCL.
Umpqua Holdings Corp (NASDAQ:UMPQ), dropped -1.18% and closed at $15.11 in the last trading session. The last trading range of the stock ranges between $15.09 and $15.26. The company’s Market capitalization is $3.40 Billion with the total Outstanding Shares of 220.21 million. Umpqua Holdings Corporation, through its auxiliaries, engages in the commercial and retail banking, and retail brokerage businesses. It operates through Community Banking and Home Lending segments. The Community Banking segment provides loan and deposit products to business and retail customers. The Home Lending segment originates, sells, and services residential mortgage loans. It also offers various deposit products, such as non-interest bearing checking accounts, interest bearing checking and savings accounts, money market accounts, and certificates of deposit; financial planning, trust, and investments services to high net worth individuals; and retail brokerage and investment advisory services. The companys loan products include loans for business and commercial customers, counting accounts receivable and inventory financing, multi-family loans, equipment loans, commercial equipment leases, international trade, real estate construction loans, permanent financing, small business administration program financing, and capital markets and treasury administration services; loan products for small businesses; commercial and industrial loans; residential real estate loans for the construction, purchase, and refinancing of residential owner-occupied and rental properties; and consumer loans, such as secured and unsecured personal loans, home equity and personal lines of credit, and motor vehicle loans. In addition, it provides technology-based services, counting remote deposit capture, online banking, bill pay and treasury, mobile banking, voice response banking, automatic payroll deposit programs, ATMs, product kiosks, and Website. As of December 31, 2015, the company operated commercial banking centers in 382 locations.
On the otherhand NextEra Energy Inc (NYSE:NEE), gained 0.41% and closed at $125.17 in the last trading session. The last trading range of the stock ranges between $124.10 and $125.43. During the 52-week trading session the minimum price at which share price traded, registered at $96.19 and reached to max level of $131.98. NextEra Energy, Inc., through its auxiliaries, generates, transmits, and distributes electric energy in the United States and Canada. The company generates electricity from gas, oil, solar, coal, petroleum coke, nuclear, and wind sources. As of December 31, 2015, it served about 9.5 million people through about 4.8 million customer accounts in the east and lower west coasts of Florida. The company had about 46,400 megawatts of generating capacity.